Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
As of Mar. 2024, Thermo Fisher Scientific has a Sloan Ratio of 1.17%, indicating the company is in the safe zone and there is no funny business with accruals.
Thermo Fisher Scientific Sloan Ratio % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Thermo Fisher Scientific's Sloan Ratio %
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thermo Fisher Scientific's Sloan Ratio % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's Sloan Ratio % falls into.
Thermo Fisher Scientific Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Thermo Fisher Scientific's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Thermo Fisher Scientific's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was 1361 (Jun. 2023 ) + 1715 (Sep. 2023 ) + 1630 (Dec. 2023 ) + 1328 (Mar. 2024 ) = $6,034 Mil.
Thermo Fisher Scientific's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 1540 (Jun. 2023 ) + 2414 (Sep. 2023 ) + 3723 (Dec. 2023 ) + 1251 (Mar. 2024 ) = $8,928 Mil.
Thermo Fisher Scientific's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was -443 (Jun. 2023 ) + -1181 (Sep. 2023 ) + -376 (Dec. 2023 ) + -2030 (Mar. 2024 ) = $-4,030 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific (NYSE:TMO) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2024, Thermo Fisher Scientific has a Sloan Ratio of 1.17%, indicating the company is in the safe zone and there is no funny business with accruals.
Thermo Fisher Scientific Sloan Ratio % Related Terms
Thank you for viewing the detailed overview of Thermo Fisher Scientific's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.
Thermo Fisher Scientific (Thermo Fisher Scientific) Business Description
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TMO has been successfully added to your 